Algo version: 0.98b
RHÖN-KLINIKUM is listed at the OTC Exchange
RHÖN-KLINIKUM [RKAGY]
OTC Sector: Healthcare Industry:Medical Care Facilities

Is RHÖN-KLINIKUM stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, RHÖN-KLINIKUM pays dividends. Last time was Wednesday 28th of June 2023 where the investors holding the stock on Thursday 8th of June 2023 were paid $0.08706747 per share. Over the last 10 times between 2014 and 2023, RHÖN-KLINIKUM has paid $2.26967981 with an average of $0.23 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for RHÖN-KLINIKUM 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $11.85, you would have made a loss of $-5.80 per share or -48.95%

We do not have enough data to give you this answer.

RHÖN-KLINIKUM has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.46, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.91%, which is challenging.

We have calculated the inflation risk for RHÖN-KLINIKUM to be low [0.35 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.